28 June 2024
Directa Plus plc
("Directa Plus", the "Group" or the "Company")
Directors' Participation in Fundraising
Total Voting Rights
Directa Plus (AIM: DCTA) (the "Company"), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to confirm that, further to the Company's announcement on 11 June 2024, the Directors' Intended Participation has now been effected and the following Directors have subscribed for a total of 555,555 New Ordinary Shares at the Issue Price of
Director |
New Ordinary Shares Subscribed For |
Total Number of Ordinary Shares Held |
% of Enlarged Issued Share Capital |
Giulio Cesareo, CEO |
344,446 |
4,302,674 |
4.12% |
Richard Hickinbotham, Chair |
166,666 |
266,666 |
0.26% |
Giorgio Bonfanti, CFO |
16,666 |
16,666 |
0.02% |
Sarah Cope, NED |
27,777 |
27,777 |
0.03% |
Accordingly, the Company has, conditionally, raised gross proceeds of approximately
Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM. It is expected that Admission will become effective, and that dealings in the New Ordinary Shares will commence on AIM, at 8.00 a.m. on 1 July 2024. The Enlarged Issued Share Capital, as increased by the New Ordinary Shares, immediately following Admission (and excluding any issues of shares pursuant to the exercise of any employee share incentives or options between the date of this Announcement and Admission) will be 104,418,755 Ordinary Shares.
The New Ordinary Shares, when issued, will be credited as fully paid and will rank on Admission pari passu in all respects with each other and with the Existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of issue.
Capitalised terms not otherwise defined in the text of this Announcement have the meanings given in the Circular published on 11 June 2024.
Directa Plus plc |
+39 02 36714458 |
Giulio Cesareo, CEO |
|
Giorgio Bonfanti, CFO |
|
|
|
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) |
+44 131 220 6939 |
Neil McDonald |
|
Adam Rae |
|
|
|
Singer Capital Markets Securities Limited (Joint Broker) |
+44 20 7496 3069 |
Rick Thompson |
|
Phil Davies |
|
|
|
Alma Strategic Communications |
+44 20 3405 0205 |
Justine James |
directaplus@almastrategic.com |
Hannah Campbell |
|
Kinvara Verdon |
|
Notes to Editors
Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.
This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products.
Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+(R)) have multiple applications due to its properties. These G+(R) products can be categorised into various families, with different products being suitable for specific practical applications.
Directa Plus was established in 2005 and is based in Lomazzo (
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|
||||
a) |
Name |
Richard Hickinbotham |
||||
2 |
Reason for notification |
|
||||
a) |
Position/Status |
Chairman |
||||
b) |
Initial notification/Amendment |
Initial Notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
||||
a) |
Name |
Directa Plus Plc |
||||
b) |
LEI |
213800X2DQST3K5ND898 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of
AIM: DCTA |
||||
b) |
Nature of the transaction |
Conditional agreement to subscribe for ordinary shares of |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||
e) |
Date of the transaction |
28 June 2024
|
||||
f) |
Place of the transaction |
London Stock Exchange, AIM |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|
||||
a) |
Name |
Giulio Cesareo |
||||
2 |
Reason for notification |
|
||||
a) |
Position/Status |
CEO |
||||
b) |
Initial notification/Amendment |
Initial Notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
||||
a) |
Name |
Directa Plus Plc |
||||
b) |
LEI |
213800X2DQST3K5ND898 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of
AIM: DCTA |
||||
b) |
Nature of the transaction |
Conditional agreement to subscribe for ordinary shares of |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||
e) |
Date of the transaction |
28 June 2024
|
||||
f) |
Place of the transaction |
London Stock Exchange, AIM |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|
||||
a) |
Name |
Giorgio Bonfanti |
||||
2 |
Reason for notification |
|
||||
a) |
Position/Status |
CFO |
||||
b) |
Initial notification/Amendment |
Initial Notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
||||
a) |
Name |
Directa Plus Plc |
||||
b) |
LEI |
213800X2DQST3K5ND898 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of
AIM: DCTA |
||||
b) |
Nature of the transaction |
Conditional agreement to subscribe for ordinary shares of |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||
e) |
Date of the transaction |
28 June 2024
|
||||
f) |
Place of the transaction |
London Stock Exchange, AIM |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|
||||
a) |
Name |
Sarah Cope |
||||
2 |
Reason for notification |
|
||||
a) |
Position/Status |
Non-Executive Director |
||||
b) |
Initial notification/Amendment |
Initial Notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
||||
a) |
Name |
Directa Plus Plc |
||||
b) |
LEI |
213800X2DQST3K5ND898 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of
AIM: DCTA |
||||
b) |
Nature of the transaction |
Conditional agreement to subscribe for ordinary shares of |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||
e) |
Date of the transaction |
28 June 2024
|
||||
f) |
Place of the transaction |
London Stock Exchange, AIM |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.